Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential display

[1]  K. Kohno,et al.  A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.

[2]  M. Condorelli,et al.  Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion , 1996, Nature Medicine.

[3]  J. Yodoi,et al.  Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. , 1995, Cancer research.

[4]  K. Kohno,et al.  Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis (*) , 1995, The Journal of Biological Chemistry.

[5]  M. Arpin,et al.  Functional differences between L- and T-plastin isoforms , 1994, The Journal of cell biology.

[6]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[7]  J. Mills,et al.  The cytoskeleton and membrane transport. , 1994, Current opinion in nephrology and hypertension.

[8]  K. Kohno,et al.  Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. , 1994, Cancer research.

[9]  W. Dalton,et al.  Expression of cytokeratin confers multiple drug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Matsudaira,et al.  Identification of I-plastin, a human fimbrin isoform expressed in intestine and kidney , 1994, Molecular and cellular biology.

[11]  M. Mutoh,et al.  Active Efflux System for Cisplatin in Cisplatin‐resistant Human KB Cells , 1994, Japanese journal of cancer research : Gann.

[12]  G. Chu,et al.  Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. , 1994, The Journal of biological chemistry.

[13]  K. Kohno,et al.  Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line. , 1993, The Journal of urology.

[14]  T. Ishikawa,et al.  Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. , 1993, The Journal of biological chemistry.

[15]  S. Howell,et al.  In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. , 1993, The Journal of clinical investigation.

[16]  C. Lin,et al.  Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. , 1993, Journal of Biological Chemistry.

[17]  K. Keyomarsi,et al.  Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. , 1992, Cancer research.

[18]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[19]  J. Matthews,et al.  Microfilament-dependent activation of Na+/K+/2Cl- cotransport by cAMP in intestinal epithelial monolayers. , 1992, The Journal of clinical investigation.

[20]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[21]  M. Shapero,et al.  Generation of region– and species–specific expressed gene probes from somatic cell hybrids , 1992, Nature Genetics.

[22]  N. Saijo,et al.  Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. , 1991, Cancer research.

[23]  M. Cohen,et al.  Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. , 1991, Carcinogenesis.

[24]  R. Aebersold,et al.  Correction of the N-terminal sequences of the human plastin isoforms by using anchored polymerase chain reaction: identification of a potential calcium-binding domain , 1990, Molecular and cellular biology.

[25]  A. M. van der Bliek,et al.  Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. , 1990, Cancer research.

[26]  K. Kohno,et al.  Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. , 1990, Biochemical and biophysical research communications.

[27]  K. Kohno,et al.  Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. , 1989, Cancer research.

[28]  A. Eastman,et al.  DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. , 1989, Biochemistry.

[29]  R. Aebersold,et al.  Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts. , 1988, Molecular and cellular biology.

[30]  A. Fojo,et al.  Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. , 1988, Cancer research.

[31]  D. Hamer,et al.  Overexpression of metallothionein confers resistance to anticancer drugs. , 1988, Science.

[32]  Waygood Eb,et al.  Sequence of cloned enzyme IIN-acetylglucosamine of the phosphoenolpyruvate:N-acetylglucosamine phosphotransferase system of Escherichia coli. , 1988 .

[33]  A. Eastman,et al.  Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). , 1988, Biochemistry.

[34]  K. Williams,et al.  Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Pastan,et al.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[37]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[38]  J. Riordan,et al.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.

[39]  B. Jockusch,et al.  Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes , 1984, Cell.

[40]  P. Chambon,et al.  Is actin a transcription initiation factor for RNA polymerase B? , 1984, The EMBO journal.

[41]  P. Loehrer,et al.  Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.

[42]  B. Spiegelman,et al.  Fibronectin modulation of cell shape and lipogenic gene expression in 3t3-adipocytes , 1983, Cell.

[43]  A. Feinberg,et al.  Hypomethylation of ras oncogenes in primary human cancers. , 1983, Biochemical and biophysical research communications.

[44]  H. Türler,et al.  SV40 DNA injected into Xenopus oocyte nuclei is transcribed by RNA polymerase B. , 1979, Cell biology international reports.